Beth Israel Deaconess Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2003

  1. Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: A novel target of thiazolidinediones

    Circulation, Vol. 107, Núm. 21, pp. 2664-2669

  2. Soluble CD40L: Risk prediction after acute coronary syndromes

    Circulation, Vol. 108, Núm. 9, pp. 1049-1052